New findings on the efficacy of COVID-19 vaccines from Public Health England (PHE) show the jabs are having a “real world impact” against the pandemic. Health Secretary Matt Hancock praised the roll out in a press conference yesterday, where he hailed the “good news” of data showing protection against coronavirus.
PHE’s study is based on analysis of testing data, which confirms findings from a previous study which said the jabs offer protection against serious bouts of COVID-19.
With more data, there has now seen a longer period of time to catch any sign immunity wears off.
A single dose of either the the Pfizer-BioNTech and Oxford-AstraZeneca reduces the risk of getting symptomatic disease by around 60 percent, based on data from those over 70 years old.
For those aged over 80, protection against hospitalisation is around 80 percent.
The Pfizer jab is also 85 percent effective at stopping people aged over 80 from dying from COVID-19, with PHE arriving at the figure as Pfizer’s jab has been approved for longer than Oxford’s.
READ MORE: Vaccine supply fears: NHS letter warns ‘significant reduction’ of jabs
Speaking at yesterday’s Downing Street press conference, Mary Ramsay, head of immunisation at PHE, said “we now have even more confidence in the vaccines” as data shows its efficacy.
She added: “The good news is things are continuing to show that these vaccines are protective.
“Those effects are maintained for several weeks — they don’t go away even with a single dose.
“Overall, this is really translating into seeing a decline in deaths and serious cases from this infection.
“It means that every day we vaccinate more people we are preventing more deaths.”
However, NHS England has warned local health organisations there will be a “significant reduction in the weekly supply” of jabs next month.
In a letter, groups have been told by the NHS there has been a “reduction in national inbound vaccines supply” and tells them to “ensure no further appointments are uploaded” to booking systems in April.
Mr Hancock said during the briefing vaccine supply was “lumpy”, and added the NHS regularly sent out “technical letters” that explained the “ups and downs” of supply.
A spokesperson for the AstraZeneca said: “Our UK domestic supply chain is not experiencing any disruption and there is no impact on our delivery schedule.”
Yesterday saw another 5,758 cases and 141 deaths within 28 days of a positive coronavirus test recorded.
In total, the UK has recorded 4,274,579 cases and 125,831 deaths.
In addition, 25,273,226 first doses of coronavirus vaccine have been administered as of yesterday.
Over 50s will be offered a first dose of vaccine by April 15, according to Mr Hancock yesterday.